stars 1 stars 2 stars 3

OncoRNA SA is a subsidiary of OncoDNA SA, a leading genomics and theranostics company focused on precision medicine for cancer and genetic diseases. Our mission of OncoRNA is to manufacture and commercialize Personalized RNA Cancer Immuno-Therapy (PRCIT) potentially a fast, high-performant, and cost-effective personalized immunotherapies for cancer patients. Our therapy utilizes a proprietary technology that combines small neoantigen mRNA (snmRNA) pool technology with lipid nanoparticle (LNP) technology, enabling the design of personalized mRNA cancer vaccines. By stimulating the patient's immune system to target and eliminate tumor cells based on specific mutations, OncoRNA's PRCIT offers a groundbreaking approach to cancer immunotherapy.

OncoRNA Questions

Jean-Pol Detiffe is the co-Founder OncoRNA www.oncorna.eu of OncoRNA.

2 people are employed at OncoRNA.

OncoRNA is based in Charleroi, Walloon Region.

Top OncoRNA Employees

View Similar People
Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users